Stem-Cell-Based Anti-Aging Ingredient Under Development, Biotech Firm Says
This article was originally published in The Rose Sheet
Executive Summary
A biotech firm that specializes in therapeutic products derived from human stem cells has a skin rejuvenation ingredient in the works, according to International Stem Cell Corporation's April 21 release
You may also be interested in...
Lifeline For Aging Consumers: A Chat With International Stem Cell Corp's CEO
Oceanside, Calif.-based International Stem Cell Corporation recently announced that Lifeline Skin Care, an anti-aging range based on the biotechnology firm's parthenogenetic stem-cell technology, is available to the public through the brand's website following a soft debut in November.
Lifeline For Aging Consumers: A Chat With International Stem Cell Corp's CEO
Oceanside, Calif.-based International Stem Cell Corporation recently announced that Lifeline Skin Care, an anti-aging range based on the biotechnology firm's parthenogenetic stem-cell technology, is available to the public through the brand's website following a soft debut in November.
International Stem Cell Corporation
ISCO says its subsidiary Lifeline Skin Care is targeting late summer or fall of 2010 for a line of three cosmetic products based on the firm's stem cell technology. "Early human trials show that these cosmetic products moisturize skin and strongly indicate the ability to decrease the depth of wrinkles and provide factors that lead to anti-aging effects," according to April 8 release. The forthcoming line combines extracts from human parthenogenetic stem cells (hpSC) with a vitamin complex and relies on nanotechnology to deliver active ingredients to damaged skin, says Oceanside, California-based ISCO, which has partnered with fellow Californian Cosmetic Enterprises, Ltd. to formulate and package its offering. Company notes that use of hpSC "avoid[s] critical ethical issues by eliminating the need to use fertilized embryos and can be immune-matched to large segments of the population." "The Rose Sheet" spoke with ISCO Chairman Kenneth C. Aldrich in April of last year (1"The Rose Sheet" April 27, 2009)